Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
12,055,479
-
Share change
-
-207,680
-
Total reported value
-
$83,665,328
-
Put/Call ratio
-
35%
-
Price per share
-
$6.94
-
Number of holders
-
27
-
Value change
-
-$1,526,233
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2018
As of 31 Dec 2018,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,055,479 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Sapphire Star Partners LP, Yorktown Management & Research Co Inc, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Eqis Capital Management, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.